Page last updated: 2024-11-03

risperidone and Pyomyositis

risperidone has been researched along with Pyomyositis in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Pyomyositis: An intramuscular suppuration of the large skeletal muscle groups. It is associated with INFECTION such as STAPHYLOCOCCUS AUREUS and PYODERMA. It was known as a tropical disease but is increasing among the immunocompromised (IMMUNOCOMPROMISED HOST). Symptoms include muscle pain, FEVER, and leucocytosis. It has been diagnosed by MRI SCANS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, EM1
Marcelin, JR1
Sohail, R1
Ramar, K1

Other Studies

1 other study available for risperidone and Pyomyositis

ArticleYear
Necrotising pyomyositis complicating intramuscular antipsychotic administration.
    BMJ case reports, 2015, Jun-08, Volume: 2015

    Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Daptomycin; Female; Gram-Positive Cocci; Humans;

2015